Le Lézard
Classified in: Health, Business
Subjects: NPT, WOM, CXP, MAT

KESSEL MEDintim GmbH, WCG Cares and Population Services International Announce Launch of Cayatm Diaphragm and Cayatm Gel in Niger


FRANKFURT, Germany and SAN DIEGO and WASHINGTON, July 15, 2019 /PRNewswire/ -- KESSEL MEDintim, WCG Cares (WCG) and Population Services International (PSI) announced the launch of the Cayatm Diaphragm and Cayatm Gel in Niger.

www.wcgcares.org (PRNewsfoto/WCG)

The introduction of the Cayatm Diaphragm and Cayatm Gel in Niger is supported by the Expanding Effective Contraceptive Options (EECO) project, which is funded by the United States Agency for International Development (USAID). The EECO project, led by WCG and implemented in partnership with PSI, was designed to support the introduction of new and improved contraceptive methods that address method-related reasons for non-use of family planning to better meet the reproductive health needs of women and girls worldwide. The launch of the Cayatm Diaphragm and Cayatm Gel, a non-hormonal, discreet and reusable barrier method, supports WCG's and PSI's joint efforts to expand access to an array of contraceptive options. PSI will market and distribute the Cayatm Diaphragm and Cayatm Gel in Niger's capital of Niamey, training community health workers and healthcare providers to offer the method to women alongside other options within the context of informed choice.

Niger has one of the world's highest fertility rates, with women having more than seven children in their lifetime on average, in part due to extremely low use of contraception. KESSEL MEDintim, WCG and PSI are dedicated to increasing access to a full range of contraceptive options in Niger, including those that respond to preferences for non-hormonal, on-demand methods like the Cayatm Diaphragm and Cayatm Gel. Unlike previous iterations of the diaphragm, the Cayatm Diaphragm is "one size fits most," eliminating the need for a provider fitting in countries like Niger with shortages of trained healthcare providers. 

"Our market research shows that women and men desire more contraceptive options that are within their control and have no side effects," said Moumouni Boubacar, EECO Project Manager at PSI Niger. "The Cayatm Diaphragm puts power in the hands of the couple."

"Women's contraceptive needs change throughout their lives and they need methods that align with their unique circumstances," said Shannon Bledsoe, WCG Executive Director. "The introduction of this on-demand, non-hormonal method gives women in Niger one more contraceptive choice."

Media Contact:

Courtney Stachowski
Program Manager
[email protected]
+1 858-314-4025

SOURCE WCG Cares


These press releases may also interest you

at 00:39
World Malaria Day is marked each year on April 25. World Health Organization (WHO) gave as the theme for World Malaria Day 2024 Accelerating the fight against malaria for a more equitable world. WHO stated that malaria not only continues to directly...

25 avr 2024
The report titled "Anti-Adhesion Products Market by Product Type (Natural Adhesion Barriers, Synthetic Adhesion Barriers), Product Form (Film Formulation, Gel Formulation, Liquid Formulation), Application, End-User - Global Forecast 2024-2030" is now...

25 avr 2024
Product: Meat and vegetable products Issue: Food - Microbial Contamination - Listeria Distribution:British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

25 avr 2024
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...

25 avr 2024
Greenbrook TMS Inc. ("Greenbrook" or the "Company") today announced its fiscal year ended December 31, 2023 ("Fiscal 2023") operational and financial results. All values in this news release are in United States dollars, unless otherwise stated....

25 avr 2024
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...



News published on and distributed by: